The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
PropertyValue
has minor subject area list Acute Disease; Adult; Bone Marrow; Humans; Kaplan-Meier Estimate; Middle Aged; Prognosis; Treatment Outcome
information resource reference Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden. Blood Cancer J. 2020 08 07; 10(8):81.
label Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden.
Search Criteria
  • Burden
  • disease